Stephen M. F. Jamieson
0000-0002-5485-9211
Publication & Citation Trends
Publications
0 total
Systemic CYP3A inhibition by ritonavir enables selective targeting of hypoxic tumour cells by prodrugs of DNA-PK inhibitors
Cited by 1
Semantic Scholar
Platinum(II) complexes of fluorinated pyrrole carbothioamides: enhanced anticancer activity and overcoming cisplatin resistance.
Cited by 0
Semantic Scholar
Whole‐genome CRISPR‐Cas9 knockout screens identify SHOC2 as a genetic dependency in NRAS‐mutant melanoma OA
Cited by 3
Semantic Scholar
CRISPR screens with trastuzumab emtansine in HER2-positive breast cancer cell lines reveal new insights into drug resistance
Cited by 7
Semantic Scholar
Site-Selective Zwitterionic Poly(caprolactone-carboxybetaine)-Growth Hormone Receptor Antagonist Conjugate: Synthesis and Biological Evaluation.
Cited by 2
Semantic Scholar
Identification of 6-Anilino Imidazo[4,5-c]pyridin-2-ones as Selective DNA-Dependent Protein Kinase Inhibitors and Their Application as Radiosensitizers OA
Cited by 3
Semantic Scholar
Clinical relevance and therapeutic predictive ability of hypoxia biomarkers in head and neck cancer tumour models OA
Cited by 4
Semantic Scholar
Biotin functionalization of 8-hydroxyquinoline anticancer organometallics: low in vivo toxicity but potent in vitro activity.
Cited by 1
Semantic Scholar
Fragment-based and structure-guided discovery of perforin inhibitors. OA
Cited by 2
Semantic Scholar
Research Topics
Crystallization and Solubility Studies
(87)
X-ray Diffraction in Crystallography
(87)
Metal complexes synthesis and properties
(37)
Ferrocene Chemistry and Applications
(26)
Cancer, Hypoxia, and Metabolism
(23)
Affiliations
University of Auckland
Auckland University of Technology
Cancer Society of New Zealand
Cancer Research Horizons
Maurice Wilkins Centre